Diabetes has become an increasingly common disease, with statistics showing that roughly 8.8% of the global population suffering from the disease. This report takes a closer look at the global diabetes therapies market.
- Advertising -
The World Health Organization (WHO) reports that over 425 million globally suffer from diabetes mellitus. Also known simply as diabetes, it's a chronic metabolic disorder that's characterized by high blood sugar levels. It generally occurs when either the pancreas doesn't produce a sufficient amount of insulin, or when cells in a person's body don't effectively respond to insulin. Regardless, diabetes is an all-too-common disease that has some serious side effects and risks.
- Advertising -
There are actually several different types of diabetes, the most common of which is type 2. Type 2 diabetes is characterized by insulin resistance. In other words, people who suffer from type 2 diabetes have cells in their body don't respond to the insulin produced by their pancreas. This disease was previously known as insulin-dependent diabetes, but it has since become known as type 2 diabetes. Statistics show that type 2 diabetes is the most common type of diabetes, accounting for roughly nine in 10 cases of all diabetes worldwide.
Type 1 diabetes, on the other hand, is characterized by the pancreas's inability to produce a sufficient amount of insulin. It's normally brought on by the loss of beta cells in the pancreas. As the pancreas loses its beta cells, it's no longer able to produce a sufficient amount of insulin, thus leading to elevated blood sugar levels and other common symptoms of diabetes.
The good news is that there are therapies available to treat diabetes. Unfortunately, no cure is available for diabetes, but therapies can minimize its effects so that it doesn't cause serious or long-lasting complications for individuals. Some diabetes therapies consist of regular insulin injections. If a person's pancreas doesn't produce a sufficient amount of insulin, for example, he or she can take an insulin shot. It's an easy and effective way to increase the amount of insulin in the blood and, therefore, minimize the effects of diabetes.
The Diabetes Therapies Global Market Opportunities And Strategies To 2023 report by ReportsnReports is a comprehensive study of the global diabetes therapies market. Featuring 150 pages, it offers an in-depth analysis of the market and where it's headed. Within this report, you'll learn more about current and future prospective scenarios associated with the global diabetes therapies market. Whether you currently suffer from diabetes, or if you work in the diabetes therapy market, you should consider accessing this report.
Some of the key diabetes therapies vendors profiled in this report include Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., Merck & Company, C.H. Boehringer Sohn AG & Ko. KG.